首页> 外文期刊>Pharmacology and Toxicology: An International Journal >Microdialysis sampling of carbamazepine, phenytoin and phenobarbital in subcutaneous extracellular fluid and subdural cerebrospinal fluid in humans: an in vitro and in vivo study of adsorption to the sampling device.
【24h】

Microdialysis sampling of carbamazepine, phenytoin and phenobarbital in subcutaneous extracellular fluid and subdural cerebrospinal fluid in humans: an in vitro and in vivo study of adsorption to the sampling device.

机译:在人的皮下细胞外液和硬脑膜下脑脊液中对卡马西平,苯妥英钠和苯巴比妥进行微透析采样:对采样装置的吸附的体内和体外研究。

获取原文
获取原文并翻译 | 示例
       

摘要

The purpose of the study was to determine if binding of the drugs to the sampling equipment during microdialysis would influence the results for carbamazepine, phenytoin and phenobarbital. In vitro experiments with microdialysis catheters and separate parts of catheters were performed to estimate the degree of drug binding to the dialysis equipment. A mathematical model to calculate drug binding and recovery is proposed. In vivo protein unbound carbamazepine concentrations in subcutaneous extracellular fluid at different flow rates (6 patients), unbound carbamazepine (1 patient) and unbound phenobarbital (I patient) in subdural cerebrospinal fluid and subcutaneous extracellular fluid were estimated and the in vivo data were compared to the in vitro results and data generated by the mathematical model. Binding to the soft outlet polyurethane tubing was extensive and variable for phenytoin, which precluded in vivo testing, but limited and more predictable for carbamazepine and phenobarbital. None of the three compounds bound to the hard internaltubing. Phenytoin and phenobarbital did not bind to the dialysis membrane, while a small degree of binding may be present for carbamazepine. In vivo estimates of carbamazepine protein unbound subcutaneous extracellular concentrations by microdialysis, adjusted for binding to the plastic tubing, were 81% of protein unbound plasma concentrations. In single case studies, subdural cerebrospinal fluid and subcutaneous extracellular levels of carbamazepine and phenobarbital were similar and when corrected for binding to the plastic tubings they were also close to protein unbound plasma concentrations. Microdialysis can be used for reliable estimations of protein unbound carbamazepine and possibly phenobarbital concentrations when drug binding to the plastic tubing is considered. Reliable estimation of unbound phenytoin is not possible at present.
机译:该研究的目的是确定微透析过程中药物与采样设备的结合是否会影响卡马西平,苯妥英钠和苯巴比妥的结果。用微透析导管和导管的分开部分进行了体外实验,以评估药物与透析设备的结合程度。提出了计算药物结合和回收率的数学模型。估计硬膜下脑脊液和皮下细胞外液中不同流速的皮下细胞外液中的体内蛋白质未结合的卡马西平浓度(6例患者),未结合的卡马西平(1例患者)和未结合的苯巴比妥(I例患者),并将体内数据与数学模型生成的体外结果和数据。苯妥英钠与软出口聚氨酯管的结合广泛且变化多端,因此无法进行体内试验,但对于卡马西平和苯巴比妥而言则有限且更可预测。三种化合物均未结合硬质内部管道。苯妥英钠和苯巴比妥不与透析膜结合,而卡马西平可能有少量结合。经微透析的体内估计卡马西平蛋白未结合的皮下细胞外浓度经调整与塑料管的结合后,为蛋白未结合血浆浓度的81%。在单例研究中,硬膜下脑脊液和卡马西平和苯巴比妥的皮下细胞外水平相似,当校正与塑料管的结合后,它们也接近蛋白质未结合血浆浓度。当考虑到药物与塑料管的结合时,微透析可用于可靠地估计未结合的卡马西平和可能的苯巴比妥浓度。目前尚无法可靠地估计未结合的苯妥英钠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号